Close Menu

Here in Marco Island, Fla., giant jellyfish may have claimed the beach, but genome scientists have taken charge of the local Marriott hotel for the annual Advances in Genome Biology & Technology conference. While Thursday was the first official day of the event, Wednesday's pre-meeting workshop on next-gen sequencing was every bit as jam-packed as the rest of the sessions so far. Richard Gibbs from Baylor offered an overview of the market as it stands right now, noting that alongside the impressive performance of many of these machines still comes a lot of hype about what's possible.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

NPR reports the US Food and Drug Administration has approved a treatment for a genetic disorder that causes rapid aging.

Late-stage testing indicates the AstraZeneca and Oxford University SARS-CoV-2 vaccine can have up to 90 percent efficacy, the Associated Press reports.

ScienceInsider reports Nature Communications is reviewing a paper on mentorship following social media criticism arguing it is sexist.

In PLOS this week: method to account for sequencing errors in phylogenies, study of influenza A in Switzerland, and more.